Date Name Title Filing Type Shares Traded Price Total Held
Dec 03, 2009
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 100,000 $8.77 688,235
Dec 03, 2009
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 100,000 -- --
Oct 29, 2009
SVP F&A, CFO, Treas & Asst Sec
SVP F&A, CFO, Treas & Asst Sec Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 4,643 $8.77 42,073
Oct 29, 2009
SVP F&A, CFO, Treas & Asst Sec
SVP F&A, CFO, Treas & Asst Sec Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 4,643 -- --
Oct 27, 2009
Director, CEO and President, Ten Percent Owner
Director, CEO and President, Ten Percent Owner Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 31,611 $10.44 132,058
Oct 27, 2009
Director, CEO and President, Ten Percent Owner
Director, CEO and President, Ten Percent Owner Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 31,611 -- --
Sep 01, 2009
VP Regul Devel & Med Safety
VP Regul Devel & Med Safety Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 3,308 $8.50 70,264
Sep 01, 2009
VP Regul Devel & Med Safety
VP Regul Devel & Med Safety Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,000 $8.50 76,956
Sep 01, 2009
VP Regul Devel & Med Safety
VP Regul Devel & Med Safety Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 858 $8.50 67,814
Sep 01, 2009
VP Regul Devel & Med Safety
VP Regul Devel & Med Safety Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,000 -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.